Dx Deals: Veracyte Acquires Convergent Genomics for up to $180 Million
The deal gives the oncology-focused Veracyte a boost in bladder cancer detection
The deal gives the oncology-focused Veracyte a boost in bladder cancer detection
The lab giant and the Michigan health system will build a 100,000-square-foot lab as part of a new business
The deal is expected to be a big boost for Illumina’s next-generation sequencing platforms
The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health
Recent inroads into testing of water for dialysis equipment illustrates Quest’s expanded scope with deals
Becton Dickinson divisions responsible for $3.4 billion in annual revenue are on the block
Quest Diagnostics will find out as it launches a new health coaching business that relies on lab testing, via its Pack Health subsidiary
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation